A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Recruiting

I'm Interested

Trial ID: NCT03941379

Purpose

The purpose of this observational research study is to follow participants who have been treated with either bel-sar or received alternate treatment (sham, standard of care therapy, etc.) while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness in these subjects. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.

Official Title

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Stanford Investigator(s)

Prithvi Mruthyunjaya, MD, MHS
Prithvi Mruthyunjaya, MD, MHS

Professor of Ophthalmology and, by courtesy, of Radiation Oncology

Eligibility


Inclusion Criteria:

   - Have been clinically diagnosed with primary IL or CM at the time of entry to a
   previous Aura Biosciences sponsored clinical trial.

   - Have received AU-011 bel-sar or assigned to a different cohort or treatment arm (sham,
   SoC, etc.) an observation cohort in a previous Aura sponsored clinical trial.

Exclusion Criteria:

- None

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Mariana Nunez
mnunez1@stanford.edu

New Trial Alerts